Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.35% | 62.98 | 1.0% | $459.39m | |
| AMGN | Amgen, Inc. | 0.41% | 241.49 | 1.3% | $450.37m | |
| BIIB | Biogen, Inc. | -0.22% | 285.50 | 1.4% | $388.18m | |
| ILMN | Illumina, Inc. | -0.38% | 324.72 | 3.5% | $319.30m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.14% | 235.83 | 1.9% | $300.51m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.10% | 385.94 | 2.6% | $230.09m | |
| EXAS | EXACT Sciences Corp. | -1.92% | 88.06 | 24.0% | $200.47m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.68% | 113.27 | 2.0% | $195.19m | |
| ITCI | Intra-Cellular Therapies, Inc. | -1.43% | 26.25 | 9.0% | $173.29m | |
| INCY | Incyte Corp. | -0.15% | 80.50 | 2.5% | $149.14m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.84% | 127.90 | 14.6% | $142.47m | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | -1.21% | 56.42 | 11.4% | $131.86m | |
| SGEN | Seattle Genetics, Inc. | 1.25% | 109.00 | 6.1% | $126.99m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.97% | 88.27 | 4.3% | $108.23m | |
| A | Agilent Technologies, Inc. | 0.79% | 90.17 | 1.6% | $106.55m |
Company Profile
La Jolla Pharmaceutical Co. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. Its products includes LJPC-501, LJPC-401 and LJPC-0118. LJPC-501 is the proprietary formulation for angiotensin II. The LJPC-401 is the formulation of hepcidin, which is an endogenous peptide hormone and LJPC-0118 is La Jolla's investigational product for the treatment of severe malaria. The company was founded in 1989 and is headquartered in San Diego, CA.